ATLANTA (AP) – A treatment that helps the immune system fight deadly blood cancers is showing early signs of promise against some solid tumors, giving hope that this approach might be extended to more common cancers in the future.
The treatment, called CAR-T (car-tee) therapy, involves genetically modifying some of a patient’s own cells in the lab to help them recognize and attack cancer.
The first of these CAR-T therapies came out two years ago for some forms of leukemia and lymphoma. Two small studies now suggest the therapy might be tweaked to fight cancers in the lining of the chest or in soft tissue and bones.
Results were discussed Sunday at an American Association for Cancer Research conference in Atlanta.
